Mirian Gom 
The Enugu State Ministry of Health has issued a public health alert over the alleged circulation of counterfeit Augmentin 625mg tablets, warning residents and healthcare providers to remain vigilant amid fears that the fake medicine may have entered the state’s pharmaceutical supply chain.
The warning was issued by Enugu State Commissioner for Health, George Ugwu, in a statement released on Thursday through the ministry’s Public Relations Officer, Chidiogo Ugodu, stating that intelligence reports indicate that counterfeit versions of Augmentin 625mg tablets are circulating with the same Batch Number AC3N as the genuine product manufactured by GSK.
The commissioner, however, noted that the fake products carry inconsistent manufacturing and expiry dates, showing a manufacturing date of September 2025 and an expiry date of 2028.
Health authorities said further inspection revealed textural inconsistencies and poor-quality packaging seals, raising serious concerns about the safety, quality and effectiveness of the counterfeit medication.
“The counterfeit tablets exhibit textural errors and poor-quality packaging seals, which raise significant concerns about their safety, quality and effectiveness,” the statement said.
Ugwu urged members of the public to purchase medicines only from licensed pharmacies and accredited healthcare facilities to reduce the risk of exposure to fake drugs.
“Providers and the general public should carefully inspect all Augmentin 625mg tablets before use,” he advised. Enugu Warns Over Fake Augmentin Circulation
The commissioner also called on healthcare professionals, pharmacists and medicine vendors to strengthen surveillance and immediately report any suspected counterfeit products.
“Anyone who suspects possession or sale of the counterfeit product should immediately report it to the nearest health authority or the Enugu State Ministry of Health,” he added.
About the Author
Hussaini Ibrahim 
Korede Abdullah 